Journal article
Controlled trial of budesonide–formoterol as needed for mild asthma
- Abstract:
-
BACKGROUND
In double-blind, placebo-controlled trials, budesonide–formoterol used on an as-needed basis resulted in a lower risk of severe exacerbation of asthma than as-needed use of a short-acting β2-agonist (SABA); the risk was similar to that of budesonide maintenance therapy plus as-needed SABA. The availability of data from clinical trials designed to better reflect clinical practice would be beneficial.
METHODS
We conducted a 52-week, randomized, open-label, par...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Bibliographic Details
- Publisher:
- Massachusetts Medical Society Publisher's website
- Journal:
- New England Journal of Medicine Journal website
- Volume:
- 380
- Issue:
- 21
- Pages:
- 2020-2030
- Publication date:
- 2019-05-19
- Acceptance date:
- 2019-04-05
- DOI:
- EISSN:
-
1533-4406
- ISSN:
-
0028-4793
- Pmid:
-
31112386
- Source identifiers:
-
1004158
Item Description
- Language:
- English
- Pubs id:
-
pubs:1004158
- UUID:
-
uuid:51972817-1b8a-4a46-8838-c33827e0ffa0
- Local pid:
- pubs:1004158
- Deposit date:
- 2019-06-24
Terms of use
- Copyright holder:
- Massachusetts Medical Society
- Copyright date:
- 2019
- Notes:
- © 2019 Massachusetts Medical Society. All rights reserved.
If you are the owner of this record, you can report an update to it here: Report update to this record